Literature DB >> 25510223

[Diagnostic for Charcot foot].

S G Hofstaetter1, K Trieb.   

Abstract

BACKGROUND: Early recognition of Charcot foot can save a long period of suffering for the patient, high doctor and hospital costs and ultimately amputation.
OBJECTIVES: This article aims to raise awareness of the diagnostics of Charcot foot also known as diabetic neuropathic osteoarthropathy (DNOAP) and the possible differential diagnostic options (e.g. diabetic foot, erysipelas and peripheral arterial occlusive disease).
MATERIAL AND METHODS: Clinical diagnostic pathways and classifications are presented and the resulting treatment options are discussed.
RESULTS: In recent years new technologies for wound treatment and interventional radiological optimization of vessels have been developed. Many promising surgical options are available for stabilizing and reconstructimg a plantigrade foot.
CONCLUSION: Treatment of Charcot foot should be based on a structured diagnosis and classification. In addition to conservative treatment new surgical options are also available.

Entities:  

Mesh:

Year:  2015        PMID: 25510223     DOI: 10.1007/s00132-014-3052-1

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  10 in total

Review 1.  The Charcot foot in diabetes.

Authors:  Lee C Rogers; Robert G Frykberg; David G Armstrong; Andrew J M Boulton; Michael Edmonds; Georges Ha Van; Agnes Hartemann; Frances Game; William Jeffcoate; Alexandra Jirkovska; Edward Jude; Stephan Morbach; William B Morrison; Michael Pinzur; Dario Pitocco; Lee Sanders; Dane K Wukich; Luigi Uccioli
Journal:  J Am Podiatr Med Assoc       Date:  2011 Sep-Oct

Review 2.  Osteomyelitis in the diabetic foot: diagnosis and management.

Authors:  Frances L Game
Journal:  Med Clin North Am       Date:  2013-05-04       Impact factor: 5.456

3.  Diagnosis and treatment of diabetic foot infections.

Authors:  Benjamin A Lipsky; Anthony R Berendt; H Gunner Deery; John M Embil; Warren S Joseph; Adolf W Karchmer; Jack L LeFrock; Daniel P Lew; Jon T Mader; Carl Norden; James S Tan
Journal:  Plast Reconstr Surg       Date:  2006-06       Impact factor: 4.730

4.  Pathogenesis and medical management of diabetic Charcot neuroarthropathy.

Authors:  Janice V Mascarenhas; Edward B Jude
Journal:  Med Clin North Am       Date:  2013-09       Impact factor: 5.456

5.  The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic.

Authors:  D G Armstrong; W F Todd; L A Lavery; L B Harkless; T R Bushman
Journal:  J Am Podiatr Med Assoc       Date:  1997-06

6.  The dysvascular foot: a system for diagnosis and treatment.

Authors:  F W Wagner
Journal:  Foot Ankle       Date:  1981-09

7.  High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study.

Authors:  L Prompers; M Huijberts; J Apelqvist; E Jude; A Piaggesi; K Bakker; M Edmonds; P Holstein; A Jirkovska; D Mauricio; G Ragnarson Tennvall; H Reike; M Spraul; L Uccioli; V Urbancic; K Van Acker; J van Baal; F van Merode; N Schaper
Journal:  Diabetologia       Date:  2006-11-09       Impact factor: 10.122

Review 8.  Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem.

Authors:  Bulent M Ertugrul; Benjamin A Lipsky; Oner Savk
Journal:  Diabet Foot Ankle       Date:  2013-11-05

9.  Etiology, pathophysiology and classifications of the diabetic Charcot foot.

Authors:  Nikolaos Papanas; Efstratios Maltezos
Journal:  Diabet Foot Ankle       Date:  2013-05-21

10.  Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot Neuro-Arthropathy: a systematic review.

Authors:  Tamara E Milne; Joseph R Rogers; Ewan M Kinnear; Helen V Martin; Peter A Lazzarini; Thomas R Quinton; Frances M Boyle
Journal:  J Foot Ankle Res       Date:  2013-07-30       Impact factor: 2.303

  10 in total
  1 in total

1.  [Charcot foot masked by erysipelas and peripheral arterial disease].

Authors:  A Haep; S Murday; A Risse; D Nashan; H F Ständer
Journal:  Hautarzt       Date:  2018-04       Impact factor: 0.751

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.